Development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli

In Vitro Cellular and Developmental Biology - Plant

Volumn 38, Issue 1, 2002, Pages 11-17

  Streatfield, Stephen J ^a   Mayor, Jocelyne M ^a   Barker, Donna K ^a   Brooks, Christopher ^a   Lamphear, Barry J ^a   Woodard, Susan L ^a   Beifuss, Katherine K ^a   Vicuna, Debra V ^a   Massey, Leigh Anne ^a   Horn, Michael E ^a   Delaney, Donna E ^a   Nikolov, Zivko L ^a   Hood, Elizabeth E ^a   Jilka, Joseph M ^a   Howard, John A ^a  

^a Prodigene Inc   (United States)

Author keywords

Enterotoxigenic Escherichia coli; Heat labile toxin; Protein stabilization; Subcellular targeting; Transgene expression; Transgenic corn

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; SYNTHETIC CONSTRUCT; ZEA; ZEA MAYS;

EID: 18244376179     PISSN: 10545476     EISSN: None     Source Type: Journal    
DOI: 10.1079/IVP2001247     Document Type: Conference Paper

References (29)

1. Efficacy of a food plant-based oral cholera toxin B subunit vaccine
2. The epidemiology of cholera and enterotoxigenic E. coli diarrheal disease
3. Epidemiology of traveller's diarrhea and relative importance of various pathogens
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. DAG, a gene required for chloroplast differentiation and palisade development in Antirrhinum majus
6. Transgenic plants for therapeutic proteins: Linking upstream and downstream strategies
7. Medical molecular farming: Production of antibodies, biopharmaceuticals and edible vaccines in plants
8. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhance the level of toxin-neutralizing antibodies
9. Transgenic plants as factories for biopharmaceuticals
10. Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin
11. Oral immunization with a recombinant bacterial antigen produced in transgenic plants
12. Assembly in vivo of enterotoxin from Escherichia coli: Formation of the B subunit oligomer
13. Commercial production of avidin from transgenic maize: Characterization of transformant, production, processing, extraction and purification
14. High efficiency transformation of maize (Zea mays L.) mediated by Agrobacterium tumefaciens
15. Liposomes containing anti-idiotypic antibodies: An oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces
16. Nucleotide sequence comparison between heat-labile toxin B-subunit cistrons from Escherichia coli of human and porcine origin
17. Intranasal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection
18. Transgenic plants as vaccine production systems
19. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): Potatoes expressing a synthetic LT-B gene
20. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: Receptor binding is essential and induces differential modulation of lymphocyte subsets
21. Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain
22. Plant-based vaccines: Unique advantages
23. 1-ELISA) procedure
24. Oral B-subunit whole-cell vaccines against cholera and enterotoxigenic Escherichia coli diarrhea
25. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato
26. 1 ganglioside compared to its coligenoid
27. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei
28. Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report)
29. Commercial production of aprotinin in transgenic maize seeds